Guaranteed Irish launch ‘Pharmaceutical and Healthcare Month’ to call on Government to ensure early access to new medicines for patients
- Organisation currently developing submission paper for Government outlining support required for pharmaceutical sector
- Opportunity for Guaranteed Irish and Government to work together to establish Ireland as a ‘practice-leader’ in pharmaceutical sector
Guaranteed Irish today announced that ‘Pharmaceutical and Healthcare Month’ will take place in October, highlighting the pivotal role that this sector plays in Ireland’s economy and calling for Ireland to be at the forefront of its European peers in terms of early access to new medicines.
Guaranteed Irish is currently working closely with their members in the pharmaceutical industry to develop a submission paper that will be presented to Government in October. This paper will outline the support required to ensure the pharmaceutical sector remains in robust health in Ireland, with a particular focus on access to new medicines and overcoming existing barriers to continual innovation and R&D.
A range of events to mark ‘Pharmaceutical and Healthcare Month’ will take place during the month of October, including a round-table discussion with key political representatives. With each of the top-ten pharmaceutical companies represented in Ireland, Guaranteed Irish will be asking the Government to work in conjunction with them to establish the country as a ‘practice-leader’ in this field.
Speaking at the launch, Brid O’Connell, CEO, Guaranteed Irish said:
“The Irish pharmaceutical sector is thriving, with the world’s top ten pharmaceuticals based here. We are the 7th largest exporter of medicinal and pharmaceutical products in the world and the sector continues to go from strength to strength – providing high tech, exciting career opportunities and contributing significantly to local communities across Ireland. It is crucial that this contribution is recognised by the Irish Government. Patients are at the very heart of this industry and we are delighted to be working with MSD Ireland and our other members in this field to highlight the opportunity that Ireland has to be at the forefront of Europe in ensuring faster access for patients to new medicines.”
Ger Brennan, Managing Director of MSD Ireland (Human Health), added:
“MSD has been a proud member of Guaranteed Irish for over ten years, playing an active part in the communities in which we operate and creating sustainable and long-term jobs nationwide. We welcome the announcement that October will showcase the important work conducted in the pharmaceutical sector in Ireland and will highlight the opportunities for Ireland to adopt innovative approaches to ensure patients gain early access to new medicines and treatments. At MSD Ireland, we take a collaborative approach in all that we do and we are committed to working closely with all of our stakeholders to ensure we play a role in delivering innovative approaches and solutions in all elements of our business.”
In addition to MSD, other leading pharmaceutical and healthcare members of Guaranteed Irish include AbbVie, BD, Hollister Inc., Ipsen, Forest Tosara Ltd, PPL Biomechanics, KCI Medical Ireland and Nutricia Ireland.